Related Pages


■ Hazard identification and engineered nanoparticles
2009 – 2012
Project leader: NRCWE
Project members: IFA, FIOH, HSL, INRS, INSHT, INAIL Research, STAMI

The goals of the project are two fold. Firstly, to develop a mutual protocol for a comprehensive hazard identification of engineered nanoparticles involving both in vitro and in vivo tests and targeting a multitude of different health effects, i.e. cancer, inflammation, fibrogenicity, cytotoxicity, and DNA-damage, relation to pulmonary effects, neurophysiologic effects (brain damage), cardiovascular effects, and reproductive effects (foetal damage).
Secondly, the partners aim to conduct mutual projects in which the different partners contribute with tests and methods of their particular expertise.

More information: Dr. Håkan Wallin, NRCWE, e-mail



More research projects: